A senior ACCC officer has been grilled on whether staff training on criminal cartel investigations was âinadequateâ while the competition regulator ran a cartel probe into ANZâs $2.5 billion share placement in 2016.
Swiss pharmaceutical company Biogen is considering a third patent infringement lawsuit against a drug maker to shield its monopoly in Australia for blockbuster multiple sclerosis drug Tecfidera from generic competition.
Union members who allegedly urged former Qantas workers to give misleading information to the Federal Court via a survey in a lawsuit brought on behalf of 2,000 stood-down ground staff may be called to explain themselves after a judge expressed concern over their conduct.
Coffee giant Vittoria has lost its bid to register the trade mark âVictoria Coffee”, with IP Australia finding the mark could prevent other businesses from honestly describing coffee products by referring to the state of Victoria.
More than 18 months after a split emerged among the courts, the Full Federal Court will weigh in on whether judges have power to shut out unregistered group members from a class action. But given the breadth of the question for the appeals court, the issue is unlikely to be resolved there.
A judge has ruled he will not consider a separate question on whether Acciona is barred from setting off any damages payable to Lendlease in a lawsuit over the $160 million sale of its engineering business.
The Full Court is set to examine whether the Federal Court has the power to make class closure orders prior to mediation, weighing on one of the biggest unanswered questions vexing the class action regime.
The ACCC has been accused of running a “experimental test case” that tries to fit the shares market within the scope of the Competition and Consumer Act with its criminal cartel case against Citigroup, Deutsche Bank and several prominent banking executives over a $2.5 billion ANZ share placement.
Two landmark class actions seeking damages from the Victorian government for economic losses suffered during last year’s second wave of COVID-19 have been thrown out, but one of the cases will be given a second chance to proceed.
JPMorgan Australia chairman Rob Priestley told Citigroup and Deutsche Bank executives not to âpanicâ about picking up a shortfall in the sale of ANZ shares, a court has heard in the ACCCâs criminal cartel case over a $2.5 billion ANZ share placement.